Commentary: Protecting human subjects and their data in multi-site research
Luft HS.
Med Care. 50 Suppl:S74-6. doi: 10.1097/MLR.0b013e318257ddd8.
2012-07-01
Abstract
Comparative effectiveness research is sometimes best done using routinely collected data from multiple real world settings. This raises important issues with respect to the authorizations to use the data, dealing with the multiple IRBs that may have oversight authority, and protecting it from breaches. Careful delineation of what is quality improvement vs. research-driven interventions can help with IRB reviews, especially for low-risk projects. It is impossible to totally de-identify data without markedly reducing its value for research, but creative strategies can markedly reduce the risk of advertent disclosures of patient identities.
Research topics
Related publications
View all publications- Lee CY, Chen X, Romanelli RJ, Segal JB.J Pharm Policy Pract. 9:26. doi: 10.1186/s40545-016-0079-1. eCollection 2016.2016 Sep 22
- McNair PD, Luft HS.Medicare Medicaid Res Rev. 2012 Jun 1;2(2). pii: mmrr.002.02.a03. doi: 10.5600/mmrr.002.02.a03. eCollection 2012.2012 Jun 01
- Publication
Three political realities in expanding coverage for the working poor: one state's experience.
Kinney ED, Tai-Seale M, Greene JY, Murray R, Tierney W.Health Aff (Millwood). 18(4):188-92.1999 Jul 01 - Luft HS.Annu Rev Public Health. 33:377-92. doi: 10.1146/annurev-publhealth-031811-124701. Epub 2012 Jan 3.2012 Apr 01
- Luft HS.N Engl J Med. 363(15):1389-91. doi: 10.1056/NEJMp1009380.2010 Oct 07




